Abstract
5096 POSTER Clinical Trial Simulations to Assess Capecitabine Dose Reduction in Combination With Docetaxel in Second Line Treatment of Metastatic Breast Cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have